Arrhythmia in Stem Cell Transplantation

Cardiac Electrophysiology Clinics

Volumn 7, Issue 2, 2015, Pages 357-370

  Almeida, Shone O ^a   Skelton, Rhys J ^a,b   Adigopula, Sasikanth ^a   Ardehali, Reza ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Arrhythmia; Cardiomyocyte; Coupling; Electromechanical; Paracrine; Regeneration; Stem cell

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; CONNEXIN 43;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARRHYTHMOGENESIS; BONE MARROW PROGENITOR CELL; CARDIAC STEM CELL; CELL SELECTION; CELL THERAPY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; EMBRYONIC STEM CELL; EXCITATION CONTRACTION COUPLING; GAP JUNCTION; HEART ARRHYTHMIA; HEART FUNCTION; HUMAN; ISCHEMIC HEART DISEASE; MYOBLAST; NONHUMAN; PARACRINE SIGNALING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; STEM CELL TRANSPLANTATION; CARDIAC MUSCLE CELL;

ARRHYTHMIAS, CARDIAC; HUMANS; MYOCYTES, CARDIAC; STEM CELL TRANSPLANTATION;

EID: 84930273997     PISSN: 18779182     EISSN: 18779190     Source Type: Journal    
DOI: 10.1016/j.ccep.2015.03.012     Document Type: Review

References (78)

1. Bolli R., Chugh A.R., D'Amario D., et al. Effect of cardiac stem cells in patients with ischemic cardiomyopathy: initial results of the SCIPIO trial. Lancet 2011, 378:1847-1857.
2. Menasché P., Alfieri O., Janssens S., et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 2008, 117:1189-1200.
3. Chong J.J., Yang X., Don C.W., et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 2014, 510:273-277.
4. Mummery C., Ward-van Oostwaard D., Doevendans P., et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 2003, 107:2733-2740.
5. Laflamme M.A., Murry C.E. Heart regeneration. Nature 2011, 473:326-335.
6. Snir M., Kehat I., Gepstein A., et al. Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. Am J Physiol Heart Circ Physiol 2003, 285:H2355-H2363.
7. Schuldt A.J., Rosen M.R., Gaudette G.R., et al. Repairing damaged myocardium: evaluating cells used for cardiac regeneration. Curr Treat Options Cardiovasc Med 2008, 10:59-72.
8. Lyon A.R., Harding S.E., Peters N.S. Cardiac stem cell therapy and arrhythmogenicity: Prometheus and the arrows of Apollo and Artemis. JCardiovasc Transl Res 2008, 1:207-216.
9. Miyoshi S., Ikegami Y., Itabashi Y., et al. Cardiac cell therapy and arrhythmias. Circ J 2007, 71(Suppl A):A45-A49.
10. Meng X. Transdifferentiation during heart regeneration. JStem Cell Res Ther 2014, 4:188.
11. Widimsky P., Panicka M., Lang O., et al. Intracoronary transplantation of bone marrow stem cells: background, techniques, and limitations. Eur Heart J 2006, 8(Supplement H):H16-H22.
12. Oettgen P. Cardiac stem cell therapy need for optimization of efficacy and safety monitoring. Circulation 2006, 114:353-358.
13. Siminiak T., Kalmucki P., Kurpisz M. Autologous skeletal myoblasts for myocardial regeneration. JInterv Cardiol 2004, 17:357-365.
14. Scharner J., Zammit P.S. The muscle satellite cell at 50: the formative years. Skelet Muscle 2011, 1:28.
15. Koh G.Y., Klug M.G., Soonpaa M.H., et al. Differentiation and long-term survival of C2C12 myoblast grafts in heart. JClin Invest 1993, 92:1548-1554.
16. Menasché P., Hagège A.A., Vilquin J.T., et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. JAm Coll Cardiol 2003, 41:1078-1083.
17. Smits P.C., van Geuns R.J., Poldermans D., et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. JAm Coll Cardiol 2003, 42:2063-2069.
18. Reinecke H., MacDonald G.H., Hauschka S.D., et al. Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair. JCell Biol 2000, 149:731-740.
19. Gepstein L., Ding C., Rahmutula D., et al. Invivo assessment of the electrophysiological integration and arrhythmogenic risk of myocardial cell transplantation strategies. Stem Cells 2010, 28:2151-2161.
20. Roell W., Lewalter T., Sasse P., et al. Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 2007, 450:819-824.
21. Perumal Srinivasan S., Neef K., Treskes P., et al. Enhanced gap junction expression in myoblast-containing engineered tissue. Biochem Biophys Res Commun 2012, 422:462-468.
22. Abraham M.R., Henrikson C.A., Tung L., et al. Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation. Circ Res 2005, 97:159-167.
23. Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001, 7:430-436.
24. Bartunek J., Vanderheyden M., Vandekerckhove B., et al. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation 2005, 112:I178-I183.
25. Raval A.N., Schmuck E.G., Tefera G., et al. Bilateral administration of autologous CD133+ cells in ambulatory patients with refractory critical limb ischemia: lessons learned from a pilot randomized, double-blind, placebo-controlled trial. Cytotherapy 2014, 16:1720-1732.
26. Fuchs S., Baffour R., Zhou Y.F., et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. JAm Coll Cardiol 2001, 37:1726-1732.
27. Handgretinger R., Kuçi S. CD133-positive hematopoietic stem cells: from biology to medicine. Adv Exp Med Biol 2013, 777:99-111.
28. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow stem cells regenerate infarcted myocardium. Pediatr Transplant 2003, 7(Suppl 3):86-88.
29. Alvarez-Dolado M., Pardal R., Garcia-Verdugo J.M., et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003, 425:968-973.
30. Assmus B., Schächinger V., Teupe C., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002, 106:3009-3017.
31. Hare J.M., Traverse J.H., Henry T.D., et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. JAm Coll Cardiol 2009, 54:2277-2286.
32. Heldman A.W., iFede D.L., Fishman J.E., et al. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. JAMA 2014, 311:62-73.
33. Hendrikx M., Hensen K., Clijsters C., et al. Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial. Circulation 2006, 114:I101-I107.
34. Cai B., Wang G., Chen N., et al. Bone marrow mesenchymal stem cells protected post-infarcted myocardium against arrhythmias via reversing potassium channels remodelling. JCell Mol Med 2014, 18:1407-1416.
35. Dai W., Hale S.L., Kay G.L., et al. Delivering stem cells to the heart in a collagen matrix reduces relocation of cells to other organs as assessed by nanoparticle technology. Regen Med 2009, 4:387-395.
36. Hale S.L., Dai W., Dow J.S., et al. Mesenchymal stem cell administration at coronary artery reperfusion in the rat by two delivery routes: a quantitative assessment. Life Sci 2008, 83:511-515.
37. Perin E., Dohmann H.F., Borojevic R., et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003, 107:2294-2302.
38. Strauer B.E., Brehm M., Zeus T., et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002, 106:1913-1918.
39. Bergmann O., Bhardwaj R.D., Bernard S., et al. Evidence for cardiomyocyte renewal in humans. Science 2009, 324:98-102.
40. Ali S.R., Hippenmeyer S., Saadat L.V., et al. Existing cardiomyocytes generate cardiomyocytes at a low rate after birth in mice. Proc Natl Acad Sci U S A 2014, 111:8850-8855.
41. Senyo S.E., Steinhauser M.L., Pizzimenti C.L., et al. Mammalian heart renewal by pre-existing cardiomyocytes. Nature 2013, 493:433-436.
42. Nadal-Ginard B., Anversa P., Kajstura J., et al. Cardiac stem cells and myocardial regeneration. Novartis Found Symp 2005, 265:142-154. [discussion: 155-7, 204-11].
43. Torella D., Ellison G.M., Méndez-Ferrer S., et al. Resident human cardiac stem cells: role in cardiac cellular homeostasis and potential for myocardial regeneration. Nat Clin Pract Cardiovasc Med 2006, 3(Suppl 1):S8-S13.
44. Beltrami A.P., Barlucchi L., Torella D., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003, 114:763-776.
45. Chugh A.R., Beache G.M., Loughran J.H., et al. Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation 2012, 126:S54-S64.
46. Hong K.U., Bolli R. Cardiac stem cell therapy for cardiac repair. Curr Treat Options Cardiovasc Med 2014, 16:324.
47. Messina E., De Angelis L., Frati G., et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004, 95:911-921.
48. Barile L., Gherghiceanu M., Popescu L.M., et al. Human cardiospheres as a source of multipotent stem and progenitor cells. Stem Cells Int 2013, 2013:e916837.
49. Malliaras K., Makkar R.R., Smith R.R., et al. Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction). JAm Coll Cardiol 2014, 63:110-122.
50. Capricor Allogeneic heart stem cells to achieve myocardial regeneration (ALLSTAR) 2000, National Library of Medicine (US), Bethesda (MD), NLM Identifier: NCT01458405. Available at:, Accessed January 23, 2015. https://clinicaltrials.gov/ct2/show/NCT01458405.
51. Lian X., Hsiao C., Wilson G., et al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci U S A 2012, 109:E1848-E1857.
52. Lian X., Zhang J., Azarin S.M., et al. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions. Nat Protoc 2013, 8:162-175.
53. Malliaras K., Marbán E. Cardiac cell therapy: where we've been, where we are, and where we should be headed. Br Med Bull 2011, 98:161-185.
54. Lieu D.K., Fu J.D., Chiamvimonvat N., et al. Mechanism-based facilitated maturation of human pluripotent stem cell-derived cardiomyocytes. Circ Arrhythm Electrophysiol 2013, 6:191-201.
55. Laflamme M.A., Gold J., Xu C., et al. Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol 2005, 167:663-671.
56. Zhu W.Z., Santana L.F., Laflamme M.A. Local control of excitation-contraction coupling in human embryonic stem cell-derived cardiomyocytes. PLoS One 2009, 4:e5407.
57. Ardehali R., Ali S.R., Inlay M.A., et al. Prospective isolation of human embryonic stem cell-derived cardiovascular progenitors that integrate into human fetal heart tissue. Proc Natl Acad Sci U S A 2013, 110:3405-3410.
58. Shiba Y., Fernandes S., Zhu W.Z., et al. Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 2012, 489:322-325.
59. Yang X., Pabon L., Murry C.E. Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes. Circ Res 2014, 114:511-523.
60. Zahanich I., Sirenko S.G., Maltseva L.A., et al. Rhythmic beating of stem cell-derived cardiac cells requires dynamic coupling of electrophysiology and Ca cycling. JMol Cell Cardiol 2011, 50:66-76.
61. Satin J., Itzhaki I., Rapoport S., et al. Calcium handling in human embryonic stem cell-derived cardiomyocytes. Stem Cells 2008, 26:1961-1972.
62. Kehat I., Khimovich L., Caspi O., et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 2004, 22:1282-1289.
63. Matsushita T., Oyamada M., Kurata H., et al. Formation of cell junctions between grafted and host cardiomyocytes at the border zone of rat myocardial infarction. Circulation 1999, 100:II262-268.
64. Reinecke H., Zhang M., Bartosek T., et al. Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation 1999, 100:193-202.
65. Zheng S.X., Weng Y.L., Zhou C.Q., et al. Comparison of cardiac stem cells and mesenchymal stem cells transplantation on the cardiac electrophysiology in rats with myocardial infarction. Stem Cell Rev 2013, 9:339-349.
66. Hwang H.J., Chang W., Song B.W., et al. Antiarrhythmic potential of mesenchymal stem cell is modulated by hypoxic environment. JAm Coll Cardiol 2012, 60:1698-1706.
67. Nygren J.M., Jovinge S., Breitbach M., et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 2004, 10:494-501.
68. Liao S.Y., Liu Y., Siu C.W., et al. Proarrhythmic risk of embryonic stem cell-derived cardiomyocyte transplantation in infarcted myocardium. Heart Rhythm 2010, 7:1852-1859.
69. Robey T.E., Saiget M.K., Reinecke H., et al. Systems approaches to preventing transplanted cell death in cardiac repair. JMol Cell Cardiol 2008, 45:567-581.
70. Fernandes S., Habib M., Caspi O., et al. Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats. JMol Cell Cardiol 2010, 49:941-949.
71. Shiba Y., Filice D., Fernandes S., et al. Electrical integration of human embryonic stem cell-derived cardiomyocytes in a guinea pig chronic infarct model. JCardiovasc Pharmacol Ther 2014, 19:368-381.
72. Skelton R.J., Costa M., Anderson D.J., et al. SIRPA, VCAM1 and CD34 identify discrete lineages during early human cardiovascular development. Stem Cell Res 2014, 13:172-179.
73. Kattman S.J., Witty A.D., Gagliardi M., et al. Stage-specificoptimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 2011, 8:228-240.
74. Menasché P. Stem cell therapy for heart failure: are arrhythmias a real safety concern?. Circulation 2009, 119:2735-2740.
75. Fukushima S., Varela-Carver A., Coppen S.R., et al. Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. Circulation 2007, 115:2254-2261.
76. Pak H.N., Qayyum M., Kim D.T., et al. Mesenchymal stem cell injection induces cardiac nerve sprouting and increased tenascin expression in a swine model of myocardial infarction. JCardiovasc Electrophysiol 2003, 14:841-848.
77. Makkar R.R., Lill M., Chen P.S. Stem cell therapy for myocardial repair: is it arrhythmogenic?. JAm Coll Cardiol 2003, 42:2070-2072.
78. Gnecchi M., Zhang Z., Ni A., et al. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008, 103:1204-1219.